Du Z, Pandey A, Moghadas SM, Bai Y, Wang L, Matrajt L, Singer BH, Galvani AP, Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults, Nature Medicine 2025, 1-6.
Moghadas SM, Shoukat A, Bawden CE, Langley JM, Singer BH, Fitzpatrick MC, Galvani AP. Cost-effectiveness of prefusion F protein-based vaccines against respiratory syncytial virus disease for older adults in the United States. Clinical Infectious Diseases. 2024, 78(5): 1328-1335.
Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM, Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Sah P, Vilches TN, Moghadas SM, Gondi S, Schneider EC, Singer J, Chokshi DA, Galvani AP, Return on investment of the COVID-19 vaccination campaign in New York City, JAMA Network Open 2022, 5(11): e2243127.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP, The implications of silent transmission for the control of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(30): 17513–17515.
For citation of our published studies, visit Google Scholar
Kim HM, Laskowski M, Moghadas SM, Sajad A, Asif M, A framework for comparing early warning systems across domains: a step toward a data-integrated public health EWS, IEEE Information Reuse and Integration 2014, 80-86.
Xiao Y, Moghadas SM, Impact of viral drift on vaccination dynamics and patterns of seasonal influenza, BMC Infectious Diseases 2013, 13: 589.
Laskowski M, Duvvuri VRSK, Buckeridge DL, Wu G, Wu J, Moghadas SM, Influenza H3N2 variant viruses with pandemic potential: preventing catastrophe in remote and isolated Canadian communities, Preventive Medicine 2013, 57: 910–913.
Mostaco–Guidolin LC, Towers SMJ, Buckeridge DL, Moghadas SM, Age distribution of infection and hospitalization among Canadian First Nations during the 2009 H1N1 pandemic, American Journal of Public Health 2013, 103: e39–e44.
Jaberi–Douraki M, Moghadas SM, Optimality of a time–dependent treatment profile during an epidemic, Journal of Biological Dynamics 2013, 7: 133–147.
Jaberi–Douraki M, Heffernan JM, Wu J, Moghadas SM, Optimal treatment profile during an influenza pandemic, Differential Equations and Dynamical Systems 2013, 21(3): 237–252.
Christian M, Fisman DN, Fowler R, Gomersall C, Herridge M, Hupert N, Jimenez E, Kraus P, Lawless B, Lazar N, Marshall J, Mathivha R, Moghadas SM, Muller M, Pearmain L, Rubinson L, Sprung C, Stelfox H, Tillyard A, Wax E, Zygun D, Critical care resource allocation: trying to PREEDICCT outcomes without a crystal ball, Critical Care 2013, 17: 107.
Morrison K, Xiao Y, Moghadas SM, Buckeridge DL, Using surveillance data to identify risk factors for severe H1N1 in First Nations, Online Journal of Public Health Informatics 2013, 5(1): e42.
Mostaco–Guidolin LC, Bowman CS, Greer AL, Fisman DN, Moghadas SM, Transmissibility of the 2009 H1N1 pandemic in remote and isolated Canadian communities: a modelling study, British Medical Journal Open 2012, 2: e001614.
Duvvuri VRSK, Heffernan JM, Moghadas SM, Duvvuri D, Guo H, Fisman DN, Wu J, Wu GE, The Role of cellular immunity in Influenza H1N1 population dynamics, BMC Infectious Diseases 2012, 12: 329.